Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

Brain implant company Paradromics is preparing for human trials, while President Biden's poor debate performance affected health-care stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.